Steven Cohen's CDTX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 1.58 M shares of Cidara Therapeutics, Inc. (CDTX) worth $151.12 M, representing 0.25% of the portfolio. First purchased in 2024-Q4, this short-term holding has been held for 4 quarters.
Based on 13F filings, Steven Cohen has maintained this position in CDTX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2025, adding 1.41 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Cidara Therapeutics (CDTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Cidara Therapeutics (CDTX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2024 | +6,148 | New Buy | 6,148 | $26.88 |
| Q1 2025 | +107,707 | Add 1751.90% | 113,855 | $21.54 |
| Q2 2025 | +1.41 M | Add 1242.00% | 1.53 M | $48.71 |
| Q3 2025 | +50,139 | Add 3.28% | 1.58 M | $95.76 |
Steven Cohen's Cidara Therapeutics Investment FAQs
Steven Cohen first purchased Cidara Therapeutics, Inc. (CDTX) in Q4 2024, acquiring 6,148 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Cidara Therapeutics, Inc. (CDTX) for 4 quarters since Q4 2024.
Steven Cohen's largest addition to Cidara Therapeutics, Inc. (CDTX) was in Q2 2025, adding 1,527,930 shares worth $74.43 M.
According to the latest 13F filing for Q3 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 1,578,069 shares of Cidara Therapeutics, Inc. (CDTX), valued at approximately $151.12 M.
As of the Q3 2025 filing, Cidara Therapeutics, Inc. (CDTX) represents approximately 0.25% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Cidara Therapeutics, Inc. (CDTX) was 1,578,069 shares, as reported at the end of Q3 2025.